This article is more than 5 years old. Information may no longer be current.

Abbott reports quarterly net sales of $5.37 billion

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Abbott reported third-quarter net sales of $5.37 billion, up 2% from $5.27 billion in the same quarter a year ago, according to a news release.

There was a negative impact on sales growth because of a sales disruption in the International Nutrition business, the release said.

Quarterly sales for Abbott Medical Optics were $276 million; the increase was 11.7% on an operational sales basis and 7.3% on a reported sales basis. Cataract sales reportedly experienced a double-digit increase, driven by the launch of the Tecnis OptiBlue in Japan and the Tecnis toric IOL in the United States. There was a decline in refractive sales.

Adjusted diluted earnings per share from continuing operations was $0.55, and reported diluted earnings per share from continuing operations under GAAP was $0.49.

Abbott confirmed its full-year earnings per share guidance of $1.98 to $2.04 and full-year earnings per share from continuing operations of $1.46 to $1.52.

A quarterly dividend of 57% to $0.22 per share will be payable on Feb. 15, 2014, to shareholders of record as of Jan. 15, 2014.